Ucello Biotechnology
PrivateLast Round
Series A
Extension
Jun 2, 2023
Est. Valuation
$105.8M
Total Funding Raised
$77.74M
Company Overview
Ucello Biotechnology is a biotechnology company that specializes in the research, development, and commercialization of allogeneic universal CAR-T cell therapeutic drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ucello Biotechnology Comparables
Compare Ucello Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qihan Biotech | 86% | |
| BRL Medicine Inc. | 81% | |
| Bioheng Therapeutics | 80% |
Ucello Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 2, 2023 | ||||
| Series C | Aug 11, 2022 | ||||
| Series A | Feb 10, 2022 | ||||
| Series B | Mar 30, 2021 | ||||
| Series A | Oct 18, 2018 | ||||
Angel | Mar 1, 2016 |
Ucello Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Co-Win Ventures | Series A Extension, Series A, Angel |
| Northern Light Venture Capital | Series A, Angel |
| Shenzhen Guozhong Venture Capital Management | Series A Extension |
| MPC | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2023
Raised $21M from Co-Win Ventures, MPC, and Shenzhen Guozhong.
- Feb 10, 2022
$25M round led by MPC.
Ucello Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ucello Biotechnology's valuation, stock price, and market status.
Is Ucello Biotechnology a public or private company?
Ucello Biotechnology is a private company.
What is the current stock price of Ucello Biotechnology?
Ucello Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Ucello Biotechnology worth (valuation)?
Valuation information for Ucello Biotechnology is not publicly available.
Can I buy Ucello Biotechnology stock?
Ucello Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ucello Biotechnology's last funding round?
Ucello Biotechnology's most recent funding round was Series A Extension on June 2, 2023.
Who are the main investors in Ucello Biotechnology?
Key investors in Ucello Biotechnology include MPCi.
Will Ucello Biotechnology IPO soon?
No public IPO plans have been announced for Ucello Biotechnology.
How can I track Ucello Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ucello Biotechnology's secondary market activity and sign up for updates.